Abiopharma

Other Scheme of Arrangement: Minutes of the Extraordinary General Meeting and the Scheme Meeting held on 15 July 2025

New Form 8-K - Zai Lab Ltd Filed: 2025-08-07 AccNo: 0001628280-25-038547 Size: 406 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Prestige Consumer Healthcare Inc. Filed: 2025-08-07 AccNo: 0001295947-25-000029 Size: 7 MB

New Form 8-K - Privia Health Group, Inc. Filed: 2025-08-07 AccNo: 0001759655-25-000091 Size: 525 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - HAEMONETICS CORP Filed: 2025-08-07 AccNo: 0000313143-25-000058 Size: 9 MB

New Form 10-Q - Green Thumb Industries Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104519 Size: 10 MB

New Form 8-K - Prestige Consumer Healthcare Inc. Filed: 2025-08-07 AccNo: 0001295947-25-000027 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - HAEMONETICS CORP Filed: 2025-08-07 AccNo: 0000313143-25-000056 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form EFFECT - ZyVersa Therapeutics, Inc. Filed: 2025-08-06 AccNo: 9999999995-25-002497 Size: 1 KB

New Form EFFECT - PolyPid Ltd. Filed: 2025-08-06 AccNo: 9999999995-25-002501 Size: 1 KB

LifeStance Reports Second Quarter 2025 Results

Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates

EPAM Systems, Inc. - EPAM Reports Results for Second Quarter 2025 and Raises Full Year Revenue Outlook

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™